Search results (1331)
« Back to PublicationsSINGLE-CELL MULTI-OMIC ANALYSIS UNRAVELS GENETIC AND MOLECULAR HETEROGENEITY IN TRANSFORMED MYELOPROLIFERATIVE NEOPLASMS
Rodriguez-Meira A. et al, (2020), EXPERIMENTAL HEMATOLOGY, 88, S48 - S48
Artificial intelligence-based morphological fingerprinting of megakaryocytes: a new tool for assessing disease in MPN patients.
Sirinukunwattana K. et al, (2020), Blood Adv, 4, 3284 - 3294
Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model
Philippou Y. et al, (2020), British Journal of Cancer
Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?
Cheung VTF. et al, (2020), Br J Cancer, 123, 207 - 215
Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial.
Blagden SP. et al, (2020), Lancet Oncol, 21, 969 - 977
Whole-genome sequencing of a sporadic primary immunodeficiency cohort.
Thaventhiran JED. et al, (2020), Nature, 583, 90 - 95
Whole-genome sequencing of patients with rare diseases in a national health system.
Turro E. et al, (2020), Nature, 583, 96 - 102
Heritable genetic variants in key cancer genes link cancer risk with anthropometric traits
Di Giovannantonio M. et al, (2020), Journal of Medical Genetics
ctDNA monitoring using patient-specific sequencing and integration of variant reads.
Wan JCM. et al, (2020), Sci Transl Med, 12
The BET inhibitor CPI203 promotes ex vivo expansion of cord blood long-term repopulating HSCs and megakaryocytes
ISSA F. and HESTER J., (2020), Blood
A NOVEL IN VITRO PLATFORM FOR THE PRIORITISATION AND VALIDATION OF INHIBITORS OF BONE MARROW FIBROSIS USING HUMAN BONE MARROW (BM) STROMAL CELLS
COLOMBO M. et al, (2020), HemaSphere, 4, 1 - 1168
SINGLE-CELL MULTI-OMICS REVEALS ABERRANT MEGAKARYOCYTE-PROGENITOR (MKP) SUB-FRACTIONS IN MYELOFIBROSIS (MF) AND IDENTIFIES MUTANT CLONE-SPECIFIC TARGETS
PSAILA B. et al, (2020), HemaSphere, 4, 1 - 1168
NUC-1031, use of ProTide technology to circumvent gemcitabine resistance: current status in clinical trials.
Kapacee ZA. et al, (2020), Med Oncol, 37
Enhanced engraftment of human myelofibrosis stem and progenitor cells in MISTRG mice.
Lysenko V. et al, (2020), Blood Adv, 4, 2477 - 2488
Assessing the impact of lockdown: Fresh challenges for the care of haematology patients in the COVID-19 pandemic.
Willan J. et al, (2020), Br J Haematol, 189, e224 - e227
Indirect treatment comparison of nivolumab versus placebo for the adjuvant treatment of melanoma.
Hemstock M. et al, (2020), Eur J Cancer, 132, 176 - 186
Rapid Emergence of Chronic Lymphocytic Leukemia During JAK2 Inhibitor Therapy in a Patient With Myelofibrosis.
Sousos N. et al, (2020), Hemasphere, 4